annual cash & cash equivalents:
$713.00M-$490.00M(-40.73%)Summary
- As of today (June 3, 2025), CC annual cash & cash equivalents is $713.00 million, with the most recent change of -$490.00 million (-40.73%) on December 31, 2024.
- During the last 3 years, CC annual cash & cash equivalents has fallen by -$738.00 million (-50.86%).
- CC annual cash & cash equivalents is now -54.18% below its all-time high of $1.56 billion, reached on December 31, 2017.
Performance
CC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$464.00M-$249.00M(-34.92%)Summary
- As of today (June 3, 2025), CC quarterly cash & cash equivalents is $464.00 million, with the most recent change of -$249.00 million (-34.92%) on March 31, 2025.
- Over the past year, CC quarterly cash & cash equivalents has dropped by -$282.00 million (-37.80%).
- CC quarterly cash & cash equivalents is now -70.18% below its all-time high of $1.56 billion, reached on December 31, 2017.
Performance
CC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.7% | -37.8% |
| 3 y3 years | -50.9% | -59.5% |
| 5 y5 years | -24.4% | -35.0% |
CC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.9% | at low | -62.8% | at low |
| 5 y | 5-year | -50.9% | at low | -68.0% | at low |
| alltime | all time | -54.2% | >+9999.0% | -70.2% | >+9999.0% |
CC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $464.00M(-34.9%) |
| Dec 2024 | $713.00M(-40.7%) | $713.00M(+19.6%) |
| Sep 2024 | - | $596.00M(-1.3%) |
| Jun 2024 | - | $604.00M(-19.0%) |
| Mar 2024 | - | $746.00M(-38.0%) |
| Dec 2023 | $1.20B(+9.2%) | $1.20B(+41.2%) |
| Sep 2023 | - | $852.00M(+15.4%) |
| Jun 2023 | - | $738.00M(-9.6%) |
| Mar 2023 | - | $816.00M(-26.0%) |
| Dec 2022 | $1.10B(-24.1%) | $1.10B(-5.6%) |
| Sep 2022 | - | $1.17B(-6.5%) |
| Jun 2022 | - | $1.25B(+9.0%) |
| Mar 2022 | - | $1.15B(-21.1%) |
| Dec 2021 | $1.45B(+31.3%) | $1.45B(+40.7%) |
| Sep 2021 | - | $1.03B(-9.5%) |
| Jun 2021 | - | $1.14B(+13.0%) |
| Mar 2021 | - | $1.01B(-8.8%) |
| Dec 2020 | $1.10B | $1.10B(+15.6%) |
| Sep 2020 | - | $956.00M(-7.3%) |
| Jun 2020 | - | $1.03B(+44.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $714.00M(-24.3%) |
| Dec 2019 | $943.00M(-21.5%) | $943.00M(+35.9%) |
| Sep 2019 | - | $694.00M(+10.2%) |
| Jun 2019 | - | $630.00M(-9.6%) |
| Mar 2019 | - | $697.00M(-42.0%) |
| Dec 2018 | $1.20B(-22.8%) | $1.20B(-5.8%) |
| Sep 2018 | - | $1.27B(+4.8%) |
| Jun 2018 | - | $1.22B(-15.1%) |
| Mar 2018 | - | $1.43B(-7.8%) |
| Dec 2017 | $1.56B(+72.5%) | $1.56B(+1.4%) |
| Sep 2017 | - | $1.53B(+0.4%) |
| Jun 2017 | - | $1.53B(+70.3%) |
| Mar 2017 | - | $898.00M(-0.4%) |
| Dec 2016 | $902.00M(+146.4%) | $902.00M(-5.7%) |
| Sep 2016 | - | $957.00M(+149.9%) |
| Jun 2016 | - | $383.00M(-12.0%) |
| Mar 2016 | - | $435.00M(+18.9%) |
| Dec 2015 | $366.00M(>+9900.0%) | $366.00M(+70.2%) |
| Sep 2015 | - | $215.00M(-13.0%) |
| Jun 2015 | - | $247.00M(>+9900.0%) |
| Dec 2014 | $0.00 | $0.00 |
FAQ
- What is Chemours annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Chemours?
- What is Chemours annual cash & cash equivalents year-on-year change?
- What is Chemours quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Chemours?
- What is Chemours quarterly cash & cash equivalents year-on-year change?
What is Chemours annual cash & cash equivalents?
The current annual cash & cash equivalents of CC is $713.00M
What is the all time high annual cash & cash equivalents for Chemours?
Chemours all-time high annual cash & cash equivalents is $1.56B
What is Chemours annual cash & cash equivalents year-on-year change?
Over the past year, CC annual cash & cash equivalents has changed by -$490.00M (-40.73%)
What is Chemours quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CC is $464.00M
What is the all time high quarterly cash & cash equivalents for Chemours?
Chemours all-time high quarterly cash & cash equivalents is $1.56B
What is Chemours quarterly cash & cash equivalents year-on-year change?
Over the past year, CC quarterly cash & cash equivalents has changed by -$282.00M (-37.80%)